Related Experiment Video
Updated: May 17, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Further Genetic Unraveling of Persistent Tachypnea of Infancy
Christina K Rapp1, Katharina Mauss-Schwarzer1, Matthias Kappler1
1Department of Paediatric Pneumology, Dr von Hauner Children's Hospital, Comprehensive Pneumology Center (CPC), German Centre for Lung Research (DZL), University of Munich, Munich, Germany.
Insights
Comprehensive genetic testing significantly improves diagnosis for persistent tachypnea of infancy (PTI/NEHI). Early exome sequencing is recommended, especially for patients with neurodevelopmental involvement, to reduce diagnostic delays.
Area of Science:
- Pediatric Pulmonology
- Medical Genetics
- Rare Diseases
Background:
- Childhood interstitial lung diseases (chILDs) are rare, heterogeneous, and often underdiagnosed chronic pulmonary disorders.
- Persistent tachypnea of infancy (PTI/NEHI) is a frequent chILD form with an unknown etiology.
- Current diagnostic approaches for PTI/NEHI may not capture the full spectrum of underlying genetic causes.
Purpose of the Study:
- To compare the diagnostic yield of comprehensive genetic testing versus limited gene testing in PTI/NEHI patients.
- To investigate the genetic underpinnings of PTI/NEHI and its association with other conditions.
- To determine if clinical characteristics influence the likelihood of obtaining a genetic diagnosis.
Main Methods:
- Exome sequencing was performed on a multicenter cohort of patients diagnosed with PTI/NEHI.
- Genetic findings were compared between PTI/NEHI patients and a control group of non-PTI/NEHI chILD patients.
- Patients were stratified by clinical characteristics, including neurodevelopmental comorbidity, to assess factors associated with genetic diagnosis.
Main Results:
- Broad genetic testing identified pathogenic variants in 12 PTI/NEHI patients, with SRRM2 and NAA10 genes frequently implicated.
- These identified genes are associated with complex disorders, including neurodevelopmental delay.
- PTI/NEHI patients with neurodevelopmental comorbidity had a significantly higher rate of genetic diagnosis (45.8%) compared to those without (1.8%).
Conclusions:
- PTI/NEHI may represent a phenotype of various genetic conditions, not a distinct disease entity.
- Comprehensive genetic testing, particularly exome sequencing, can improve diagnostic yield in PTI/NEHI.
- Early genetic evaluation, especially in cases with neurodevelopmental involvement, is crucial for reducing diagnostic delays.
Background:
Childhood interstitial lung diseases (chILDs) are rare, heterogeneous chronic pulmonary disorders that are often underdiagnosed due to their low prevalence and nonspecific clinical presentation. Persistent tachypnea of infancy (PTI), often referred to as neuroendocrine cell hyperplasia of infancy (NEHI), is 1 of the most frequent forms of chILD, although its underlying etiology remains unknown.
Research Question:
Can comprehensive genetic testing significantly improve diagnostic yield in patients with PTI/NEHI compared with limited testing of established genes?
Study Design And Methods:
We conducted a comparative genetic analysis, using exome sequencing, in a multicenter cohort of patients who had received diagnoses of PTI/NEHI and contrasted their findings with those of patients with chILD who did not meet the diagnostic criteria for PTI/NEHI (referred to as the non-PTI/NEHI group). Diagnostic yield was assessed in both groups, and patients were further stratified into subgroups to evaluate whether clinical characteristics or comorbidities differed between those with and without genetic diagnosis.
Results:
In 12 patients with PTI/NEHI, broad genetic testing identified potentially pathogenic variants associated with known human conditions. Notably, the same genes were identified across multiple individuals exclusively in the PTI/NEHI subgroup, including SRRM2 (n = 5) and NAA10 (n = 3). Both genes are associated with complex disorders primarily manifesting neurodevelopmental delay, as are the 4 other genes (BRWD3, DEPDC5, NKX2-1, UBE3B) identified in the children with PTI/NEHI. Among 79 patients with PTI/NEHI, those with neurodevelopmental comorbidity had a significantly higher likelihood of receiving a genetic diagnosis (11 of 24; 45.8%) than those without (1 of 55; Fisher exact test, P < .001).
Interpretation:
Our data further support the view that PTI/NEHI represents a phenotype rather than a disease entity and may occur in the context of various genetic conditions, including, but probably not limited to, neurodevelopmental disorders. Early genetic testing may help reduce diagnostic delays, and exome sequencing is particularly recommended in patients with PTI/NEHI with neurodevelopmental involvement.
Related Concept Videos
Pneumothorax II: Pathophysiology
Atelectasis II: Pathophysiology
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
